Differential Effects of PDE5 Inhibitors on Cardiac Dysfunction in the MDX Ouse Model of Duchenne Muscular Dystrophy

BMC pharmacology & toxicology - United Kingdom
doi 10.1186/2050-6511-14-s1-o38